Rapid Therapeutic Science Laboratories, Inc. (RTSL)
USD 0.0
(2.56%)
USD 0.0
(2.56%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -1.26 Million USD | 41.79% |
| 2021 | -2.17 Million USD | 0.0% |
| 2019 | -169.69 Thousand USD | 0.0% |
| 2017 | -2.52 Million USD | -11577.95% |
| 2016 | -21.61 Thousand USD | -79.83% |
| 2015 | -12.02 Thousand USD | 2.3% |
| 2014 | -12.3 Thousand USD | 35.1% |
| 2013 | -18.95 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -21.2 Thousand USD | 78.43% |
| 2023 Q1 | -98.29 Thousand USD | -459.5% |
| 2022 Q1 | -789.39 Thousand USD | -40.84% |
| 2022 Q2 | -128.37 Thousand USD | 83.74% |
| 2022 Q4 | 27.34 Thousand USD | 107.33% |
| 2022 Q3 | -372.9 Thousand USD | -190.48% |
| 2022 FY | -1.26 Million USD | 41.79% |
| 2021 Q2 | -532.57 Thousand USD | -2.43% |
| 2021 Q3 | 74.57 Thousand USD | 114.0% |
| 2021 FY | -2.17 Million USD | 0.0% |
| 2021 Q1 | -519.94 Thousand USD | 0.0% |
| 2021 Q4 | -560.49 Thousand USD | -851.58% |
| 2020 Q2 | -543.77 Thousand USD | -119.93% |
| 2020 Q3 | -623.74 Thousand USD | -14.71% |
| 2020 Q1 | -247.25 Thousand USD | -74.29% |
| 2019 Q4 | -141.86 Thousand USD | -578.59% |
| 2019 Q2 | -22.97 Thousand USD | -17.72% |
| 2019 Q1 | -19.51 Thousand USD | 42.65% |
| 2019 Q3 | -20.9 Thousand USD | 9.0% |
| 2019 FY | -169.69 Thousand USD | 0.0% |
| 2018 Q4 | -34.02 Thousand USD | -39.44% |
| 2018 Q3 | -24.4 Thousand USD | 73.4% |
| 2018 Q2 | -91.74 Thousand USD | 32.22% |
| 2018 Q1 | -135.36 Thousand USD | -2407.17% |
| 2017 Q4 | -5399.00 USD | -74.39% |
| 2017 Q1 | -8770.00 USD | -213.21% |
| 2017 Q2 | -8218.00 USD | 6.29% |
| 2017 FY | -2.52 Million USD | -11577.95% |
| 2017 Q3 | -3096.00 USD | 62.33% |
| 2016 Q3 | -3365.00 USD | 49.63% |
| 2016 Q4 | -2800.00 USD | 16.79% |
| 2016 FY | -21.61 Thousand USD | -79.83% |
| 2016 Q1 | -3552.00 USD | -7.64% |
| 2016 Q2 | -6681.00 USD | -88.09% |
| 2015 Q4 | -3300.00 USD | -106.9% |
| 2015 Q1 | -1500.00 USD | 0.0% |
| 2015 Q2 | -3573.00 USD | -138.2% |
| 2015 FY | -12.02 Thousand USD | 2.3% |
| 2015 Q3 | -1595.00 USD | 55.36% |
| 2014 Q4 | -1500.00 USD | 1.96% |
| 2014 Q3 | -1530.00 USD | 80.32% |
| 2014 FY | -12.3 Thousand USD | 35.1% |
| 2014 Q2 | -7773.00 USD | -34.85% |
| 2014 Q1 | -5764.00 USD | -16.44% |
| 2013 Q4 | -4950.00 USD | -10.74% |
| 2013 Q2 | -3773.00 USD | 0.0% |
| 2013 FY | -18.95 Thousand USD | 0.0% |
| 2013 Q3 | -4470.00 USD | -18.47% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -360.583% |
| IR-Med Inc. | -4.91 Million USD | 74.275% |
| Polarean Imaging plc | -12.55 Million USD | 89.939% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 388.314% |
| Avitar, Inc. | 2.73 Million USD | 146.228% |
| AVITA Medical, Inc. | -40.4 Million USD | 96.873% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | -79.706% |
| Össur hf. | 87.46 Million USD | 101.444% |
| Zecotek Photonics Inc. | -3.65 Million USD | 65.452% |
| QHSLab, Inc. | -240.15 Thousand USD | -426.042% |
| Wellstar International, Inc. | -1.79 Million USD | 29.607% |
| Össur hf. | 87.46 Million USD | 101.444% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 160.708% |
| Escalon Medical Corp. | -104.47 Thousand USD | -1109.209% |
| Aurora Spine Corporation | -446.19 Thousand USD | -183.134% |
| BrainsWay Ltd. | -4.92 Million USD | 74.359% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 86.644% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 554.441% |
| Vivos Inc. | -2.79 Million USD | 54.77% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.755% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -428.224% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 28.691% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -233.416% |
| Nanomix Corporation | -8.43 Million USD | 85.027% |
| Theraclion SA | -3.48 Million USD | 63.707% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -78.682% |
| Positron Corporation | -1.36 Million USD | 7.159% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 38.82% |
| Lombard Medical, Inc. | -29.33 Million USD | 95.693% |
| ALR Technologies Inc. | -2.94 Million USD | 57.122% |
| Stratec SE | 25.26 Million USD | 105.0% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 3243.323% |
| Heart Tronics, Inc. | 14.46 Million USD | 108.737% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -948.183% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 93.906% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -133.951% |
| VMS Rehab Systems, Inc. | -68.66 USD | -1839883.979% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 63.456% |
| Ingen Technologies, Inc. | -1.61 Million USD | 21.709% |
| Odyssey Group International, Inc. | 14.26 Million USD | 108.859% |
| United American Healthcare Corporation | -67 Thousand USD | -1785.572% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -210.036% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -99.048% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -110.023% |
| Urologix, Inc. | -6.93 Million USD | 81.77% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 79.835% |
| SS Innovations International, Inc. | -20.66 Million USD | 93.888% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -448.7% |
| Smith & Nephew plc | 425 Million USD | 100.297% |
| NIOX Group Plc | 4.6 Million USD | 127.464% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 429.147% |
| Broncus Holding Corporation | -33.22 Million USD | 96.197% |
| Brain Scientific Inc. | -9.6 Million USD | 86.852% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 86.706% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -1981.308% |